Telesis Bio

Telesis Bio Inventory

The Inventory of Telesis Bio (TBIO) as of Oct 18, 2026 is 4.03 M USD. In the previous year, Inventory was 2.20 M USD — a change of 82.95% (higher).

Inventory

4.03 MUSD

YoY

82.95%

Last updated:

Inventory of Telesis Bio is 2023 4.03 M USD. Inventory of Telesis Bio was 2022 2.20 M USD. It decreases by 82.95% higher compared to the previous year.

The Telesis Bio Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2019
712,000.00 USD
Jan 1, 2020
601,000.00 USD
Jan 1, 2021
2.37 M USD
Jan 1, 2022
2.20 M USD
Jan 1, 2023
4.03 M USD
The Telesis Bio Inventory history
YEARInventoryYoY
4.03 MUSD+82.95%
2.20 MUSD-7.09%
2.37 MUSD+294.01%
601,000.00USD-15.59%
712,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Telesis Bio Stock analysis

What does Telesis Bio do? Telesis Bio Inc, trading under the ticker TBIO with ISIN US1920032000, is a U.S.-based company headquartered in San Diego. It operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company has 212 employees and completed its initial public offering on June 18, 2021. Telesis Bio Inc's website is https://codexdna.com/. The company focuses on research and development of genomic tools for biomedical and industrial applications. Its synthetic biology solutions aim to address challenges in the multi-step process of constructing DNA and mRNA, overcoming limitations that hinder scalable production. The BioXp system, an end-to-end automated workstation, is a key product offering. The company provides BioXp systems, including the BioXp 3250 model, along with BioXp kits for generating synthetic DNA and mRNA, and benchtop reagents designed to support automated synthetic biology workflows. Additional products include eight BioXp kits, three benchtop reagent kits, and various synthetic biology solutions such as 14 SARS-CoV-2 full-length genomes and RNA controls. The company has deployed approximately 200 BioXp systems globally. Telesis Bio Inc is engaged in developing tools that enhance the efficiency and scalability of genomic research and applications. Telesis Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Telesis Bio stock

Inventory of Telesis Bio is 4.03 M USD in 2023.

Inventory of Telesis Bio changed from 2.20 M USD to 4.03 M USD, representing a 82.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Telesis Bio since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Telesis Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Telesis Bio

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Telesis Bio